Literature DB >> 29098564

Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread.

P Karayiannis1.   

Abstract

Hepatitis B virus is a member of the Hepadnaviridae family and responsible for causing acute and chronic hepatitis in humans. The current estimates of people chronically infected with the virus are put at 250 million worldwide. Immune-mediated liver damage in these individuals may lead to the development of cirrhosis and hepatocellular carcinoma later in life. This review deals with our current understanding of the virology, molecular biology, life cycle and cell-to-cell spread of this very important pathogen, all of which are considered essential for current and future approaches to antiviral treatment.

Entities:  

Keywords:  Cell-to-cell spread; Genotypes; Hepatitis B virus; Life cycle; Molecular virology; Replication

Mesh:

Year:  2017        PMID: 29098564     DOI: 10.1007/s12072-017-9829-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  82 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  A pregenomic RNA sequence adjacent to DR1 and complementary to epsilon influences hepatitis B virus replication efficiency.

Authors:  Hong Tang; Alan McLachlan
Journal:  Virology       Date:  2002-11-10       Impact factor: 3.616

3.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

4.  Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  JAMA       Date:  1967-05-01       Impact factor: 56.272

5.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

6.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

7.  Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis.

Authors:  T Gerelsaikhan; J E Tavis; V Bruss
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J.

Authors:  Kanako Tatematsu; Yasuhito Tanaka; Fuat Kurbanov; Fuminaka Sugauchi; Shuhei Mano; Tatsuji Maeshiro; Tomokuni Nakayoshi; Moriaki Wakuta; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

9.  Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.

Authors:  M Weber; V Bronsema; H Bartos; A Bosserhoff; R Bartenschlager; H Schaller
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

View more
  25 in total

Review 1.  Biological activity of quaternary ammonium salts and resistance of microorganisms to these compounds.

Authors:  Ewa Obłąk; Bożena Futoma-Kołoch; Anna Wieczyńska
Journal:  World J Microbiol Biotechnol       Date:  2021-01-11       Impact factor: 3.312

Review 2.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 3.  Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions.

Authors:  Yongzhen Liu; Stephanie Maya; Alexander Ploss
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

4.  Echinacoside promotes the proliferation of human renal tubular epithelial cells by blocking the HBX/TREM2‑mediated NF‑κB signalling pathway.

Authors:  Yufan Zhang; Qinfang Wu; Limin Zhong; Lei Wang; Dongwei Gong
Journal:  Mol Med Rep       Date:  2020-06-02       Impact factor: 2.952

Review 5.  Advances in detection of infectious agents by aptamer-based technologies.

Authors:  Hui-Yan Li; Wan-Nan Jia; Xin-Yi Li; Li Zhang; Chang Liu; Jian Wu
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

6.  Hepatitis B virus infection among oncohematologic disease patients in Central Brazil: prevalence, risk factors and immunization.

Authors:  Grécia C Pessoni; Tássia A Marinho; Megmar M Santos Carneiro; Regina M Martins; Caroline C Soares; Leandro N Silva; Marcia A Matos; Adriano M Arantes; Juliana A Teles; Nathalia C Santos; Sheila Araujo Teles
Journal:  Hematol Transfus Cell Ther       Date:  2019-03-28

7.  Identification of hepadnavirus in the sera of cats.

Authors:  Gianvito Lanave; Paolo Capozza; Georgia Diakoudi; Cristiana Catella; Leonardo Catucci; Paola Ghergo; Fabio Stasi; Vanessa Barrs; Julia Beatty; Nicola Decaro; Canio Buonavoglia; Vito Martella; Michele Camero
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

8.  Downregulation of HBx Restrains Proliferation, Migration, and Invasion of HepG2 Cells.

Authors:  Chaoqun Huang; Wei Liu; Xiaochuan Zhao; Libin Zhao; Fuxiang Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2021-05-13       Impact factor: 2.916

Review 9.  Recent Advances in Hepatitis B Treatment.

Authors:  Georgia-Myrto Prifti; Dimitrios Moianos; Erofili Giannakopoulou; Vasiliki Pardali; John E Tavis; Grigoris Zoidis
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

Review 10.  Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability.

Authors:  Marina Campos-Valdez; Hugo C Monroy-Ramírez; Juan Armendáriz-Borunda; Laura V Sánchez-Orozco
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.